Comparative evaluation of the efficacy of different marbofloxacin-based products in pigs at the nursery, growth and finish phases with clinical signs of respiratory disease

Marbofloxacin is one of the antibiotics of choice for the treatment of pigs with clinical manifestations of respiratory disease. Some commercial products on the market contain this active ingredient, and the objective of this study was to evaluate the efficacy of 3 available marbofloxacin-based pro...

Full description

Bibliographic Details
Main Authors: Caio Abercio da Silva, André Maurício Buzato, Gabriela Souza Romano, Cleandro Pazinato Dias, Kelly Lais Souza, Marco Aurélio Callegari, Rafael Humberto Carvalho
Format: Article
Language:English
Published: Universidade Estadual de Londrina 2023-03-01
Series:Semina: Ciências Agrárias
Subjects:
Online Access:https://ojs.uel.br/revistas/uel/index.php/semagrarias/article/view/46430
_version_ 1797866237156392960
author Caio Abercio da Silva
André Maurício Buzato
Gabriela Souza Romano
Cleandro Pazinato Dias
Kelly Lais Souza
Marco Aurélio Callegari
Rafael Humberto Carvalho
author_facet Caio Abercio da Silva
André Maurício Buzato
Gabriela Souza Romano
Cleandro Pazinato Dias
Kelly Lais Souza
Marco Aurélio Callegari
Rafael Humberto Carvalho
author_sort Caio Abercio da Silva
collection DOAJ
description Marbofloxacin is one of the antibiotics of choice for the treatment of pigs with clinical manifestations of respiratory disease. Some commercial products on the market contain this active ingredient, and the objective of this study was to evaluate the efficacy of 3 available marbofloxacin-based products based on the SISAAB (single injection and short-term antibiotic) concept with regard to the performance and health parameters of pigs in the nursery, growth and termination phases with clinical manifestations of respiratory disease (RD). A total of 78 animals with clinical manifestations of RD from a total of 1726 pigs were used. The animals that had RD symptoms were weighed, identified and randomly subjected to 3 treatments: T1 - Forcyl® (n = 27); T2 - Marbox® (n = 25); T3 - Resolutor® (n = 26). All treatments corresponded to a single intramuscular dose of 8 mg of marbofloxacin per kg of live weight. After treatment, clinical signs of cough and depression, water consumption, rectal temperature, performance parameters, lung lesions and the pneumonia index of the animals were evaluated. The animals that received T1 and T3 maintained a mean rectal temperature of 39.38 °C 2 days after administration. In contrast, animals in the group that received T2 had significantly higher temperatures (p = 0.068) in this period (39.53 °C). There was a greater decrease in temperature (p = 0.042) in the 24 hours after drug administration in animals that received T1 (-0.573 °C). Regarding the other performance parameters, clinical signs of cough and depression, water consumption, lung injury and the pneumonia index, no differences were observed between the marbofloxacin-based products evaluated (p > 0.05). All marbofloxacin-based products were effective in reducing the clinical signs of RD and promoting animal performance and health. However, T1 was more effective in reducing the rectal temperature of the animals.
first_indexed 2024-04-09T23:20:51Z
format Article
id doaj.art-7d2cf6f7a06b4baf8b9e82c2f6547382
institution Directory Open Access Journal
issn 1676-546X
1679-0359
language English
last_indexed 2024-04-09T23:20:51Z
publishDate 2023-03-01
publisher Universidade Estadual de Londrina
record_format Article
series Semina: Ciências Agrárias
spelling doaj.art-7d2cf6f7a06b4baf8b9e82c2f65473822023-03-21T20:30:14ZengUniversidade Estadual de LondrinaSemina: Ciências Agrárias1676-546X1679-03592023-03-0144110.5433/1679-0359.2023v44n1p343Comparative evaluation of the efficacy of different marbofloxacin-based products in pigs at the nursery, growth and finish phases with clinical signs of respiratory diseaseCaio Abercio da Silva0André Maurício Buzato1Gabriela Souza Romano2Cleandro Pazinato Dias3Kelly Lais Souza4Marco Aurélio Callegari5Rafael Humberto Carvalho6Universidade Estadual de LondrinaVetoquinol Saúde AnimalAkei Animal ResearchAkei Animal ResearchAkei Animal ResearchAkei Animal ResearchUniversidade Estadual de Londrina Marbofloxacin is one of the antibiotics of choice for the treatment of pigs with clinical manifestations of respiratory disease. Some commercial products on the market contain this active ingredient, and the objective of this study was to evaluate the efficacy of 3 available marbofloxacin-based products based on the SISAAB (single injection and short-term antibiotic) concept with regard to the performance and health parameters of pigs in the nursery, growth and termination phases with clinical manifestations of respiratory disease (RD). A total of 78 animals with clinical manifestations of RD from a total of 1726 pigs were used. The animals that had RD symptoms were weighed, identified and randomly subjected to 3 treatments: T1 - Forcyl® (n = 27); T2 - Marbox® (n = 25); T3 - Resolutor® (n = 26). All treatments corresponded to a single intramuscular dose of 8 mg of marbofloxacin per kg of live weight. After treatment, clinical signs of cough and depression, water consumption, rectal temperature, performance parameters, lung lesions and the pneumonia index of the animals were evaluated. The animals that received T1 and T3 maintained a mean rectal temperature of 39.38 °C 2 days after administration. In contrast, animals in the group that received T2 had significantly higher temperatures (p = 0.068) in this period (39.53 °C). There was a greater decrease in temperature (p = 0.042) in the 24 hours after drug administration in animals that received T1 (-0.573 °C). Regarding the other performance parameters, clinical signs of cough and depression, water consumption, lung injury and the pneumonia index, no differences were observed between the marbofloxacin-based products evaluated (p > 0.05). All marbofloxacin-based products were effective in reducing the clinical signs of RD and promoting animal performance and health. However, T1 was more effective in reducing the rectal temperature of the animals. https://ojs.uel.br/revistas/uel/index.php/semagrarias/article/view/46430AntibioticsPerformancePneumoniaCough.
spellingShingle Caio Abercio da Silva
André Maurício Buzato
Gabriela Souza Romano
Cleandro Pazinato Dias
Kelly Lais Souza
Marco Aurélio Callegari
Rafael Humberto Carvalho
Comparative evaluation of the efficacy of different marbofloxacin-based products in pigs at the nursery, growth and finish phases with clinical signs of respiratory disease
Semina: Ciências Agrárias
Antibiotics
Performance
Pneumonia
Cough.
title Comparative evaluation of the efficacy of different marbofloxacin-based products in pigs at the nursery, growth and finish phases with clinical signs of respiratory disease
title_full Comparative evaluation of the efficacy of different marbofloxacin-based products in pigs at the nursery, growth and finish phases with clinical signs of respiratory disease
title_fullStr Comparative evaluation of the efficacy of different marbofloxacin-based products in pigs at the nursery, growth and finish phases with clinical signs of respiratory disease
title_full_unstemmed Comparative evaluation of the efficacy of different marbofloxacin-based products in pigs at the nursery, growth and finish phases with clinical signs of respiratory disease
title_short Comparative evaluation of the efficacy of different marbofloxacin-based products in pigs at the nursery, growth and finish phases with clinical signs of respiratory disease
title_sort comparative evaluation of the efficacy of different marbofloxacin based products in pigs at the nursery growth and finish phases with clinical signs of respiratory disease
topic Antibiotics
Performance
Pneumonia
Cough.
url https://ojs.uel.br/revistas/uel/index.php/semagrarias/article/view/46430
work_keys_str_mv AT caioaberciodasilva comparativeevaluationoftheefficacyofdifferentmarbofloxacinbasedproductsinpigsatthenurserygrowthandfinishphaseswithclinicalsignsofrespiratorydisease
AT andremauriciobuzato comparativeevaluationoftheefficacyofdifferentmarbofloxacinbasedproductsinpigsatthenurserygrowthandfinishphaseswithclinicalsignsofrespiratorydisease
AT gabrielasouzaromano comparativeevaluationoftheefficacyofdifferentmarbofloxacinbasedproductsinpigsatthenurserygrowthandfinishphaseswithclinicalsignsofrespiratorydisease
AT cleandropazinatodias comparativeevaluationoftheefficacyofdifferentmarbofloxacinbasedproductsinpigsatthenurserygrowthandfinishphaseswithclinicalsignsofrespiratorydisease
AT kellylaissouza comparativeevaluationoftheefficacyofdifferentmarbofloxacinbasedproductsinpigsatthenurserygrowthandfinishphaseswithclinicalsignsofrespiratorydisease
AT marcoaureliocallegari comparativeevaluationoftheefficacyofdifferentmarbofloxacinbasedproductsinpigsatthenurserygrowthandfinishphaseswithclinicalsignsofrespiratorydisease
AT rafaelhumbertocarvalho comparativeevaluationoftheefficacyofdifferentmarbofloxacinbasedproductsinpigsatthenurserygrowthandfinishphaseswithclinicalsignsofrespiratorydisease